EBioMedicine 63:103202 Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, Hazlehurst JM, Guo K, LEAN trial team, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hbscher SG, Newsome PN, (2016) Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
The latest 'triple G' weight loss drug, retatrutide ('reta') is not yet available in the UK
Ultimately, the choice between TB-500 capsules, lyophilized powder, or nasal spray depends on factors such as convenience, researcher preference, and the desired mode of administration that aligns with the research or therapeutic goals
Maximum microdose ceiling typically set at 0.25 mg, which is the standard starting dose for weight loss protocols